Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion. - Straub,R.H.; Pongratz,G.; Schölmerich,J. (Arthritis Rheum, 2003)